ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1446	National Cancer Institute	Html	en	Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)–Patient Version	Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.	cancer treatment 0.700679 oral mucositis pain 0.483396 tissue 0.465551 chemotherapy 0.631313 blood cell count 0.467595 mouth problems 0.466009 PDQ Oral Complications 0.468892 oral health exam 0.469677 mouth sores 0.537291 infections 0.470414 teeth 0.49264 neck radiation therapy 0.476468 high-dose chemotherapy 0.598756 cancer information summary 0.466904 oral mucositis 0.510415 stem cell transplant 0.72121 oral complications 0.763758 patients 0.61166 cancer patients 0.469036 radiation therapy patients 0.468456 dry mouth 0.687045 neck cancers 0.467921 radiation therapy 0.972855 Chronic dry mouth 0.472069 problems 0.532519	regular oral care 0.496586 oral care 0.520388 peroxide mouth rinses 0.475847 PDQ cancer information 0.50364 head 0.475462 mucous membranes 0.503677 mouth moist 0.469166 patient 0.472618 taste changes 0.470678 National Cancer Institute 0.465975 summary 0.488366 common oral complications 0.486948 Wipe mouth 0.467118 pain 0.536314 white blood cell 0.514465 tooth decay 0.48102 mouth guards 0.465834 gum disease 0.504216 salivary glands 0.547761 Managing Oral Complications 0.485092 PDQ summary 0.468583 mouth 0.82735 Different oral complications 0.468019 milder oral complications 0.467906	CLICK HERE
1730	National Cancer Institute	Html	en	Blood-Forming Stem Cell Transplants	A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits.	red blood cells 0.400014 cancer treatment 0.26536 cord blood 0.408194 public cord blood 0.298389 bone marrow cells 0.392639 cord blood bank 0.313292 embryonic stem cells 0.414015 cord stem cells 0.382315 healthy cells 0.309763 bone marrow donation 0.293131 white blood cells 0.53145 transplanted stem cells 0.39836 HLA-matched stem cells 0.374986 clinical trials 0.346744 healthy stem cells 0.372316 stem cells 0.95315 stem cell transplant 0.291072 multiple myeloma 0.26697 Bone marrow aspiration 0.292859 cord blood banks 0.343333 immature cells 0.319355 HLA antigens 0.259199 appropriate unrelated donor 0.262231 radiation therapy 0.329306 transplantation 0.292216	blood-forming stem cells 0.415789 immature nerve cells 0.328089 Large volunteer donor 0.262362 new blood cells 0.334223 blood stem cell 0.339528 cancer cells 0.404042 special blood test 0.260646 peripheral blood stem 0.362146 anticancer drugs 0.263549 donor 0.356002 PBSCT 0.299118 patient 0.341681 marrow’s ability 0.258871 blood stem cells 0.413585 healthy bone marrow 0.302284 umbilical cord blood 0.366965 umbilical cord 0.389737 harvested cells 0.30119 commercial cord blood 0.270418 Marrow Donor Program® 0.288844 BMT 0.322432 bone marrow 0.850438 autologous transplant 0.272369 hematopoietic stem cells 0.478378	CLICK HERE
1734	National Cancer Institute	Html	en	Diethylstilbestrol (DES) and Cancer	A fact sheet about DES (a synthetic form of estrogen) and the health problems of children who were exposed to DES while in the womb.	DES grandsons 0.538814 Hatch EE 0.382563 DES exposure 0.67711 Cell Cancer Registry 0.421337 pregnant women 0.436903 mothers 0.380607 Pap test 0.370345 researchers 0.371735 pregnancy 0.387046 slightly increased risk 0.395077 DES Follow-up Study 0.632841 DES-exposed women 0.392223 health problems 0.418784 slightly higher risk 0.374572 prenatal DES exposure 0.579068 hormone replacement therapy 0.402773 possible health effects 0.424124 health effects 0.485372 women 0.613207 DES daughters 0.874038 abnormal cells 0.390363 overall cancer risk 0.3987 prenatally exposed men 0.392794 regular breast cancer 0.374945	Hormonal Transplacental Carcinogenesis 0.419307 third-generation daughters 0.375828 DES-exposed daughters 0.446699 adverse health effects 0.420665 clear cell adenocarcinoma 0.541335 unexposed women 0.492521 DES granddaughters 0.631672 studies 0.380945 National Cancer Institute 0.372742 Military medical records 0.370524 higher risk 0.376562 breast cancer risk 0.433356 breast cancer 0.508269 birth defects 0.404912 cervical intraepithelial neoplasia 0.371506 DES-exposed mothers 0.370151 DES 0.962997 squamous intraepithelial lesions 0.371888 abnormal cell changes 0.370094 Clear Cell Cancer 0.418711 et al 0.459666 New England Journal 0.400964 cancer 0.517317 risk 0.491261	CLICK HERE
1981	National Cancer Institute	Html	es	Etapa final de la vida (PDQ®)–Versión para pacientes	Sumario informativo revisado por expertos sobre el tratamiento y la atención del paciente de cáncer desde los últimos días hasta las últimas horas de vida; esto incluye los síntomas comunes, los dilemas éticos que pueden surgir y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este período.	etapa final 0.952722 alientoLa sensación 0.303004 siguientes afecciones 0.302215 Mejor comunicación 0.301527 posibles daños 0.30146 Contracciones mioclónicasLas 0.30427 siguientes tipos 0.302214 PDQ Aflicción 0.302895 PDQ Etapa final 0.30437 suficiente oxígeno 0.302526 HemorragiaLa hemorragia 0.303897 vía rectal 0.302425 obstructiva crónica 0.302498 posibles riesgos 0.304519 efectos directos 0.302483 vías respiratorias 0.375323 muerteEl estertor 0.304331 National Cancer Institute 0.30139 especial cánceres 0.30221 Mejor alivio 0.301759 próximas horas 0.302343	Instituto Nacional 0.302514 PDQ Planificar 0.312661 contracciones súbitas 0.303377 pequeñas cantidades 0.302149 importantes beneficios 0.301883 cuánta probabilidad 0.301726 Physician Data Query 0.305159 LíquidosLos pacientes 0.308282 PDQ Fatiga 0.306846 FatigaLa fatiga 0.303104 PDQ Delirium 0.307935 término instrucciones 0.301507 posibles beneficios 0.301551 nutrición parenteral 0.304251 reanimación cardiorrespiratoria 0.301653 causa sufrimiento 0.302836 Mejor perspectiva 0.301742 sufrimiento extremo 0.306751 numerosos cambios 0.308661 ReanimaciónLos pacientes 0.308108	CLICK HERE
16297	National Cancer Institute	Html	en	Medicinal Mushrooms (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of medicinal mushrooms as a treatment for people with cancer.	G. lucidum products 0.573204 adjuvant chemotherapy 0.660268 PSK-treated group 0.523648 class I–negative patients 0.557926 control group 0.693917 humoral immune parameters 0.519217 Baseline immune parameters 0.519968 PDQ cancer information 0.546523 lung cancer 0.659292 investigators 0.524722 natural killer 0.558674 turkey tail 0.569981 innate immune cells 0.545469 advanced gastric cancer 0.572653 doxorubicin -based chemotherapy 0.54683 patients 0.832482 cancer patients 0.665826 G. lucidum 0.844684 gastric cancer patients 0.617385 PSK 0.985645 adjuvant therapy 0.585553 standard cancer treatments 0.5637 G. lucidum fruit 0.543411 cancer patient plasma 0.523542	radiation therapy 0.5502 lung cancer models 0.542252 medicinal mushrooms 0.540839 protein-bound PSK 0.737238 immune response pathways 0.537187 lung cancer cohort. 0.537885 PSK recipients 0.737199 PSK adjuvant immunotherapy 0.863333 PSK group 0.883506 advanced lung cancer 0.536376 G. lucidum polysaccharides 0.77527 advanced colorectal cancer 0.532494 National Cancer Institute 0.545709 5-year survival 0.544251 direct antitumor mechanisms 0.520707 lung cancer patients 0.596507 PSK patients 0.803579 adjuvant PSK 0.861863 gastric cancer 0.807983 G. lucidum enhance 0.535434 direct antitumor 0.521271 PSK treatment 0.759609 5-year survival rates 0.518116 MHC expression–negative patients 0.571654	CLICK HERE
16562	National Cancer Institute	Html	en	Screen to Save: NCI Colorectal Cancer Outreach and Screening Initiative	NCI Colorectal Cancer Outreach and Screening Initiative aims to increase colorectal cancer screening rates among ethnically and racially diverse and rural communities nationwide.	NCI-designated Cancer Centers 0.680452 country 0.523395 evidence-based resources 0.584437 education 0.537172 National Cancer Advisory 0.70446 Alaskan Natives 0.584304 recommendations 0.526636 overall assessment 0.573123 ethnically diverse communities 0.720461 local communities 0.586899 colorectal screening rates 0.853048 outreach activities 0.578711 colorectal cancer screening 0.850894 rural areas 0.584762 colorectal cancer 0.992617 Cancer Control National 0.675464 PACHE-funded community health 0.657281 community levels 0.588626 National Outreach Network 0.661026 Health Disparities Program 0.668335 women age 0.582977 Reduce Cancer Health 0.704459 American Indians 0.579831 Colorectal Cancer Awareness 0.761387	Cancer Moonshot 0.620655 Cancer Health Disparities 0.821429 NCI Center 0.608436 Blacks/African Americans 0.579578 Save initiative 0.611204 Cancer Health Equity 0.685373 NCI Colorectal Cancer 0.830393 Regional Coordinating Directors 0.639583 diverse partner network 0.664475 Blue Ribbon Panel 0.662084 rural communities 0.646304 Geographic Management 0.573805 community health educators 0.957975 outreach efforts 0.576306 Native Hawaiians 0.58859 screening resources 0.639461 Pacific Islanders 0.584476 evidence-based colorectal cancer 0.788139 key role 0.575779 colorectal screening behaviors 0.792179 NCI-approved colorectal cancer 0.776303 additional community engagements 0.645113 Screening Initiative 0.658551 information 0.537846	CLICK HERE
16713	National Cancer Institute	Html	es	Iniciativa de Respuestas Excepcionales: Preguntas y respuestas	El Instituto Nacional del Cáncer (NCI) emprendió la Iniciativa de Respuestas Excepcionales a fin de entender la base molecular de los tumores en pacientes de cáncer que responden en forma excepcional al tratamiento, principalmente quimioterapia.	Exceptional Responders 0.786989 suficiente información 0.61563 Sequencing Identifies 0.586522 poderosa técnica 0.577603 tejido no puede usarse para otras 0.723672 siguientes criterios 0.611344 llamado data access request 0.624892 ARN mensajero 0.581431 Everolimus Sensitivity 0.593577 suficiente ácido 0.633822 Genome Sequencing 0.743091 suficiente tejido 0.888254 genes tsc1 0.601267 datos dbGAP 0.580415 estudio piloto 0.664379 tejido fijo en formol 0.691726 Exceptional Responders Data 0.636284	Exceptional Responders Initiative 0.702067 consentimiento apropiado para investigaciones 0.678722 fármacos similares. El estudio 0.741131 Instituto Nacional 0.57833 gen tsc1 0.738554 Trials Support Unit 0.638511 descubrimientos prometedores 0.585883 datos clínicos a medidata 0.649717 Revisión Central de Adultos 0.624848 extensa experiencia 0.580712 requiere varios pasos 0.583341 pacientes con respuestas 0.618767 centro biospecimen core 0.880872 tumores sólidos 0.758056 enfermedad y el 0.583796 aun pacientes 0.751408	CLICK HERE
17189	National Cancer Institute	Html	en	Sexual Health Issues in Women with Cancer	Cancer treatments such as chemotherapy, hormone therapy, and radiation may cause sexual problems in women. Conditions may include vaginal dryness, vaginal stenosis, and vaginal atrophy. Learn how to manage and treat these sexual problems.	cancer treatment 0.51645 vaginal tissue 0.532819 primary ovarian insufficiency 0.548774 endocrine therapy 0.478386 health care team 0.776749 sexual life 0.612375 support group 0.540233 gynecologic cancers 0.477639 social worker 0.530013 pelvic muscles 0.474973 sexual activity 0.559668 sexual health 0.668647 sexual intercourse 0.555683 low estrogen levels 0.65848 hair loss 0.473268 physical changes 0.478751 birth control 0.564552 Fertility Issues 0.55759 effects 0.479305 sexual problems 0.5327 hot flashes 0.548172 radiation therapy 0.542011 long term 0.480571 valuable suggestions 0.473342 vaginal dryness 0.649951	vaginal gels 0.527917 problems 0.541005 women 0.505517 cancer treatments 0.472282 treatment 0.973526 sex life 0.471664 personal health factors 0.547006 vaginal secretions 0.525892 cancer-related support services 0.536181 changes 0.511207 Vaginal stenosis 0.532538 vaginal wall 0.531486 vaginal atrophy 0.531565 hormone therapy 0.536753 sexual changes 0.501579 bladder retention 0.472634 shorter vagina 0.48061 sexual health expert 0.553722 support groups 0.47572 Breast Cancer 0.475837 doctor 0.494029 bowel function 0.475187 national organizations 0.470856 time 0.509374	CLICK HERE
17222	National Cancer Institute	Html	en	Tumor DNA Sequencing in Cancer Treatment	Tumor DNA sequencing (also called genetic profiling or genetic testing) is a test to identify DNA changes in a patient’s cancer. In some cases, this information can help determine a treatment plan.	unique DNA changes 0.327494 health care provider 0.21495 lung tumor 0.253938 tumor sequencing 0.343527 specific genetic alterations 0.302101 healthy cells 0.230873 Multigene panel tests 0.208409 health care team 0.2107 frequently used sequencing 0.320207 hereditary cancer syndromes 0.221971 health care providers 0.211937 whole-genome sequencing 0.314537 cancer types 0.228448 DNA changes 0.331071 patient care 0.205253 targeted sequencing tests 0.342426 broad tumor DNA 0.375946 heterogeneous tumor 0.233471 DNA sequencing tests 0.507176 precision medicine 0.222532 single cancer type 0.228039 lung cancer cells 0.3596 treatment 0.286045 precision medicine trials 0.205063	DNA alteration 0.251455 NCI-COG Pediatric MATCH 0.207207 inherited genetic alteration 0.228682 DNA sequence 0.253453 cancer cells 0.454035 unique genetic alterations 0.280668 sequencing tests cost 0.308627 EGFR mutation 0.209321 Broad DNA sequencing 0.411749 cancer-causing DNA changes 0.297683 way cells function 0.250384 tumor dna 0.91525 tumor dna sequencing 0.748819 DNA sequencer 0.254089 Clinical tumor DNA 0.406068 health care 0.275099 DNA sequencing test 0.405098 mRNA expression test 0.209986 breast cancer 0.203535 genetic alterations 0.703142 cancer 0.512553 standard treatment 0.204466 whole-exome sequencing 0.314247 quantitative mRNA test 0.208612	CLICK HERE
17290	National Cancer Institute	Html	es	Uso extraoficial de medicamentos en el tratamiento del cáncer	Conozca qué es el uso extraoficial o no indicado de medicamentos y el papel que desempeña en el tratamiento del cáncer.	régimen r-cvp 0.716896 régimen cmf 0.714486 régimen beacopp 0.710604 amplio uso 0.781419	Estados Unidos 0.77621 seguro médico 0.921249 siguientes razones 0.728265 régimen tac 0.710628	CLICK HERE